Skip to content

Drug interactions

Oxybutynin transdermal + Solifenacin

Severity: Moderate

Oxybutynin transdermal and Solifenacin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both are antimuscarinics used for overactive bladder, so using them together adds to anticholinergic effects including dry mouth, constipation, urinary retention and cognitive impairment. Transdermal delivery gives less dry mouth than oral oxybutynin, but systemic effects still add.

What this interaction means in plain words

Oxybutynin transdermal and Solifenacin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Additive antagonism at muscarinic receptors.

What to do

Avoid therapeutic duplication; if combined, monitor for anticholinergic adverse effects and post-void residual and stop one agent if they occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Oxybutynin transdermal and Solifenacin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Oxybutynin transdermal with Solifenacin?

MediHelp rates the interaction as moderate. Oxybutynin transdermal and Solifenacin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both are antimuscarinics used for overactive bladder, so using them together adds to anticholinergic effects including dry mouth, constipation, urinary retention and cognitive impairment. Transdermal delivery gives less dry mouth than oral oxybutynin, but systemic effects still add.

How serious is the interaction between Oxybutynin transdermal and Solifenacin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid therapeutic duplication; if combined, monitor for anticholinergic adverse effects and post-void residual and stop one agent if they occur.

What other medicines interact with Solifenacin?

MediHelp also lists interactions of Solifenacin with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Solifenacin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in